➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Merck
Dow
Boehringer Ingelheim
AstraZeneca
Johnson and Johnson

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

Breckenridge Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for BRECKENRIDGE, and what generic and branded alternatives to BRECKENRIDGE drugs are available?

BRECKENRIDGE has forty-five approved drugs.

There are three tentative approvals on BRECKENRIDGE drugs.

Drugs and US Patents for Breckenridge

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Breckenridge SUCCINYLCHOLINE CHLORIDE succinylcholine chloride INJECTABLE;INJECTION 212638-001 Oct 9, 2019 AP RX No No   Start Trial   Start Trial
Breckenridge ENTECAVIR entecavir TABLET;ORAL 208721-001 Mar 15, 2018 AB RX No No   Start Trial   Start Trial
Breckenridge RIVASTIGMINE rivastigmine FILM, EXTENDED RELEASE;TRANSDERMAL 209063-002 Nov 26, 2019 AB RX No No   Start Trial   Start Trial
Breckenridge IMATINIB MESYLATE imatinib mesylate TABLET;ORAL 205990-002 Feb 8, 2019 AB RX No No   Start Trial   Start Trial
Breckenridge PIOGLITAZONE HYDROCHLORIDE pioglitazone hydrochloride TABLET;ORAL 078472-002 Feb 13, 2013 AB RX No No   Start Trial   Start Trial
Breckenridge LANSOPRAZOLE lansoprazole CAPSULE, DELAYED REL PELLETS;ORAL 203964-002 Oct 17, 2018 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for BRECKENRIDGE drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
Express Scripts
AstraZeneca
Colorcon
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.